Wikisage, the free encyclopedia of the second generation, is digital heritage
Epilepsy: Difference between revisions
(riluzole) |
No edit summary |
||
Line 52: | Line 52: | ||
|} | |} | ||
[[File:Riluzole.svg.png|thumb|riluzole]] | [[File:Riluzole.svg.png|thumb|[[riluzole]]]] | ||
[[File:2000px-Sultiame.svg.png|thumb|sulthiame]] | [[File:2000px-Sultiame.svg.png|thumb|sulthiame]] | ||
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480532/pdf/10.1177_1756285615589711.pdf A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480532/pdf/10.1177_1756285615589711.pdf A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures] |
Latest revision as of 23:16, 29 January 2023
Classification of ethiology could divided in four categories:
- idiopathic epilepsy
- symptomatic epilepsy
- provoked epilepsy
- cryptogenic epilepsy
[1] It is difficult to distinguish between genetic and cryptogenic syndromes.
Morbility data is difficult to interpret when WHO[2] states 50-70 millions persons[3] suffers epilepsy[4]
nonadherence appears to be associated with increased health care costs, nevertheless XR-medicine appears as strategy to overcome compliance with AED[5]
Medicines | ||||
type | ,,, | ,,,, | ||
INN | Generic | slow release | ||
carbamazepine | normal | xr | ||
lamotrigine | normal | Lamictal XR[6] | ||
levetiracetam | normal | xr | ||
oxcarbazepine | oxcarbazepine | xr | ||
phenytoin | ... | xr | ||
valproate | xr | |||
topiramate | xr | |||
AED |
Diverse Mechanisms of Antiepileptic Drugs in the Development Pipeline
ILAE Classification
[7] [8] [9] [10] ILAE Overview
See also
A new perspective for Epileptic Disorders
Links
Epilepsies: diagnosis and management clinical guide
Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population
The Efficacy of Leviteracetam versus Carbamazepine for Epilepsy: A Meta-Analysis
The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs
purinergic signalling:therapeutic developments
Electroencephalography in the Diagnosis of Genetic Generalized Epilepsy Syndromes
Ranking the Leading Risk Factors for Sudden Unexpected Death in Epilepsy
References: |
|